Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Jul;205(1):71-87.
doi: 10.1111/bjh.19414. Epub 2024 Apr 25.

Cancer-associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline

Affiliations
Practice Guideline

Cancer-associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline

Raza Alikhan et al. Br J Haematol. 2024 Jul.

Abstract

A shared decision on the most appropriate agent for the treatment of cancer-associated thrombosis should consider the following factors, which should be reassessed as patients continue along their cancer care pathway: risk of bleeding; tumour site; suitability of oral medications; potential for drug-drug interactions; and patient preference and values regarding choice of drug. Continuing anticoagulation beyond 6 months in patients with cancer-associated venous thromboembolism and active cancer is recommended.

Keywords: anticoagulation; cancer; venous thromboembolism; venous thrombosis.

PubMed Disclaimer

References

REFERENCES

    1. Ahmad AS, Ormiston‐Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 2015;112(5):943–947.
    1. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta‐analysis. PLoS Med. 2012;9(7):e1001275.
    1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population‐based case‐control study. Arch Intern Med. 2000;160(6):809–815.
    1. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166(4):458–464.
    1. Sibson KR, Biss TT, Furness CL, Grainger JD, Hough RE, Macartney C, et al. BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy. Br J Haematol. 2018;180(4):511–525.

Publication types

LinkOut - more resources